Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Multiple sclerosis in Isfahan, Iran: an update.

Literature DB >> 24326673

Multiple sclerosis in Isfahan, Iran: an update.

Masoud Etemadifar¹, Seyed-Hossein Abtahi², Mojtaba Akbari³, Richard T Murray⁴, Sreeram V Ramagopalan⁵, Mahboobeh Fereidan-Esfahani⁶.

Abstract

Entities: Disease

Mesh：

Year: 2013 PMID： 24326673 DOI： 10.1177/1352458513516531

Source DB: PubMed Journal: Mult Scler ISSN： 1352-4585 Impact factor: 6.312

Keyword Cloud
Cited

× No keyword cloud information.

10 in total

1. The distinctive contrast of multiple sclerosis epidemiology between Persians and Armenian minority community of Isfahan city, Iran.

Authors: Masoud Etemadifar; Seyed-Mohammadamin Nourian; Mojtaba Akbari; Seyed-Hossein Abtahi; Parto Nasri; Mahboobeh Fereidan-Esfahani
Journal: Neurol Sci Date: 2015-01-11 Impact factor: 3.307

2. The Relationship Between Religious Beliefs and Quality of Life Among Patients With Multiple Sclerosis.

Authors: Fatemeh Vizehfar; Azita Jaberi
Journal: J Relig Health Date: 2017-10

3. Cost-effectiveness analysis of rituximab versus natalizumab in patients with relapsing remitting multiple sclerosis.

Authors: Mehdi Rezaee; Mohammad Hossein Morowvat; Maryam Poursadeghfard; Armin Radgoudarzi; Khosro Keshavarz
Journal: BMC Health Serv Res Date: 2022-01-28 Impact factor: 2.655

4. Familial aggregation of multiple sclerosis: Results from the national registry of the disease in Saudi Arabia.

Authors: Mohammed AlJumah; Hessa Al Otaibi; Ghada Al Towaijri; Ahmed Hassan; Abid Kareem; Mamdouh Kalakatawi; Saad Alrajeh; Mousa Al Mejally; Hussein Algahtani; Ali Almubarak; Sadaga Alawi; Shireen Qureshi; Yaser Al Malik; Ashraf El-Metwally; Sahar Shami; Samah Ishak; Reem Bunyan
Journal: Mult Scler J Exp Transl Clin Date: 2020-10-12

5. miR-141 and miR-200a, Revelation of New Possible Players in Modulation of Th17/Treg Differentiation and Pathogenesis of Multiple Sclerosis.

Authors: Reza Naghavian; Kamran Ghaedi; Abbas Kiani-Esfahani; Mazdak Ganjalikhani-Hakemi; Masoud Etemadifar; Mohammad Hossein Nasr-Esfahani
Journal: PLoS One Date: 2015-05-04 Impact factor: 3.240

10. Assessing the Risk Factors for Multiple Sclerosis in Women of Reproductive Age Suffering the Disease in Isfahan Province.

Authors: Mehri Rejali; Sayed Mohsen Hosseini; Maryam Sadat Kazemi Tabaee; Masoud Etemadifar
Journal: Int J Prev Med Date: 2016-03-10

10 in total

Multiple sclerosis in Isfahan, Iran: an update.

1. The distinctive contrast of multiple sclerosis epidemiology between Persians and Armenian minority community of Isfahan city, Iran.

2. The Relationship Between Religious Beliefs and Quality of Life Among Patients With Multiple Sclerosis.

3. Cost-effectiveness analysis of rituximab versus natalizumab in patients with relapsing remitting multiple sclerosis.

4. Familial aggregation of multiple sclerosis: Results from the national registry of the disease in Saudi Arabia.

5. miR-141 and miR-200a, Revelation of New Possible Players in Modulation of Th17/Treg Differentiation and Pathogenesis of Multiple Sclerosis.

6. Clinical Presentations and Phenotypic Spectrum of Multiple Sclerosis at a University Hospital in Saudi Arabia.

7. Epidemiology of multiple sclerosis in Iran: A systematic review and meta-analysis.

Review 8. Multiple sclerosis in Iran: An epidemiological update with focus on air pollution debate.

9. Economic burden of multiple sclerosis: a cross-sectional study in Iran.

10. Assessing the Risk Factors for Multiple Sclerosis in Women of Reproductive Age Suffering the Disease in Isfahan Province.